Beranda › Kanker Esofagus
Uji klinis Kanker Esofagus yang merekrut di AS
110 studi untuk Kanker Esofagus merekrut peserta di lokasi di seluruh Amerika Serikat.
Kota dengan studi terbanyak
- Houston, TX36 studi
- Boston, MA23 studi
- New York City, NY22 studi
- Nashville, TN19 studi
- St. Louis, MO17 studi
- Pittsburgh, PA15 studi
- Los Angeles, CA15 studi
- Grand Rapids, MI14 studi
- Baldwin Park, CA14 studi
- Philadelphia, PA13 studi
- San Antonio, TX12 studi
- Dallas, TX11 studi
- Chicago, IL11 studi
- Arlington, VA11 studi
- Rochester, MN11 studi
- San Diego, CA10 studi
- Durham, NC10 studi
- Cleveland, OH10 studi
- Portland, OR10 studi
- Washington, DC9 studi
- Atlanta, GA9 studi
- Denver, CO9 studi
- Detroit, MI9 studi
- Birmingham, AL8 studi
- Orlando, FL8 studi
- Milwaukee, WI8 studi
- Tampa, FL8 studi
- Minneapolis, MN8 studi
- Indianapolis, IN8 studi
- Toledo, OH7 studi
- Aurora, CO7 studi
- Edison, NJ7 studi
- Santa Monica, CA7 studi
- Seattle, WA7 studi
- Mountain View, CA7 studi
- Salt Lake City, UT7 studi
- Baltimore, MD7 studi
- Kansas City, MO7 studi
- Columbus, OH7 studi
- Queens, NY6 studi
Berdasarkan negara bagian
- Alabama8 studi
- Alaska4 studi
- Arizona11 studi
- Arkansas6 studi
- California41 studi
- Colorado19 studi
- Connecticut8 studi
- Delaware3 studi
- Distrik Columbia4 studi
- Florida33 studi
- Georgia11 studi
- Idaho3 studi
- Illinois15 studi
- Indiana12 studi
- Iowa6 studi
- Kansas8 studi
- Kentucky8 studi
- Louisiana5 studi
- Maine3 studi
- Maryland13 studi
- Massachusetts25 studi
- Michigan22 studi
- Minnesota19 studi
- Missouri20 studi
- Montana4 studi
- Nebraska7 studi
- New Jersey9 studi
- New Mexico6 studi
- New York28 studi
- North Carolina16 studi
- North Dakota4 studi
- Ohio22 studi
- Oklahoma8 studi
- Oregon11 studi
- Pennsylvania29 studi
- Rhode Island3 studi
- South Carolina7 studi
- South Dakota4 studi
- Tennessee21 studi
- Texas46 studi
- Utah8 studi
- Virginia16 studi
- Washington11 studi
- West Virginia3 studi
- Wisconsin16 studi
Studi yang baru diperbarui
Teks studi resmi (Bahasa Inggris)
Evaluation of Cell Changes in Blood and Tissue in Cancers of the Lung, Esophagus and Lung Lining
Menerima pesertaStudi observasional
Usia 2 hingga 120 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT00242723Distance-Based Exercise to Preserve Function and Prevent Disability
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT07059884A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT06465069Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
Menerima pesertaSukarelawan sehat diterima
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT07283939A Study to Evaluate Investigational Agents With or Without Pembrolizumab (MK-3475) in Participants With Advanced Esophageal Cancer Previously Exposed to Programmed Cell Death 1 Protein (PD-1)/ Programmed Cell Death Ligand 1 (PD-L1) Treatment (MK-3475-06B)
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT05319730Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT06265285Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 40 hingga 75 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT05334069A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT06760819A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT06172478A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT07090499A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid Tumors
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT07814248A Phase 1 Study of IM-1617 in Participants With Advanced Cancer
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 29 Sep 2026 · NCT07578571Upfront Chemotherapy With Radiation Therapy (CRT) Followed by Chemotherapy in Localized Esophageal Adenocarcinoma
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 29 Sep 2026 · NCT07603375Phase 1 Study of PF-08046033 in Advanced Solid Tumors
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07519655DESTINY-PANTUMOUR04
Menerima pesertaStudi observasional
Usia 18 hingga 130 · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07124000A Study of Pembrolizumab With Trastuzumab and Chemotherapy in People With Esophagogastric Cancer
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT06123338Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT06047379Pan-tumor MRD Study
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT06605404sFOLFOXIRI in Advanced Gastroesophageal Cancer, (SAGE)
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT05332002Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT06128551A Study of LY4257496 in Participants With Cancer (OMNIRAY)
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07114601A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07213791Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 21 Sep 2026 · NCT05983432Prehabilitation in High-risk Oncologic Surgery
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 21 Sep 2026 · NCT07638410Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Gastric or Esophageal Cancer.
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Sep 2026 · NCT07217704Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.